Literature DB >> 19447520

Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration.

Minho Won1, Kyeong Ah Park, Hee Sun Byun, Young-Rae Kim, Byung Lyul Choi, Jang Hee Hong, Jongsun Park, Jeong Ho Seok, Young-Ho Lee, Chung-Hyun Cho, In Sang Song, Yong Kyung Kim, Han-Ming Shen, Gang Min Hur.   

Abstract

BACKGROUND/AIMS: Based on the observation of biphasic induction of SGK1 expression in the regenerating liver, we investigated the role of SGK1 in the regulation of MEK/ERK signaling pathway which plays a crucial role in regulating growth and survival signaling.
METHODS: To determine the role of SGK1 in the activation of MEK/ERK signaling cascade, we infected primary hepatocytes with recombinant adenoviral vector encoding SGK1, and assessed its effect on the MEK/ERK signaling pathway.
RESULTS: Partial hepatectomy resulted in the biphasic transcriptional induction of SGK1 in regenerating liver tissues. Infection of primary hepatocytes with an adenoviral vector encoding SGK1 enhanced the ERK phosphorylation under serum-starved conditions and this was blocked by the expression of kinase-dead SGK1. SGK1 was found to physically interact with ERK1/2 as well as MEK1/2. Furthermore, SGK1 mediated the phosphorylation of ERK2 on Ser(29) in a serum-dependent manner. Replacement of Ser(29) to aspartic acid, which mimics the phosphorylation of Ser(29), enhanced the ERK2 activity as well as the MEK/ERK complexes formation.
CONCLUSIONS: SGK1 expression during liver regeneration is a part of a signaling pathway that is necessary for enhancing ERK signaling activation through modulating the MEK/ERK complex formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447520     DOI: 10.1016/j.jhep.2009.02.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis.

Authors:  Jian-An Bai; Gui-Fang Xu; Li-Jun Yan; Wei-Wen Zeng; Qian-Qian Ji; Jin-Dao Wu; Qi-Yun Tang
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis.

Authors:  Lennard Y W Lee; Connor Woolley; Thomas Starkey; Sujata Biswas; Tia Mirshahi; Chiara Bardella; Stefania Segditsas; Shazia Irshad; Ian Tomlinson
Journal:  Clin Cancer Res       Date:  2018-10-15       Impact factor: 12.531

3.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

4.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

5.  Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways.

Authors:  Harish N Vasudevan; Pierre Mazot; Fenglei He; Philippe Soriano
Journal:  Elife       Date:  2015-05-07       Impact factor: 8.140

6.  Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.

Authors:  Cristina Talarico; Lucia D'Antona; Domenica Scumaci; Agnese Barone; Francesco Gigliotti; Claudia Vincenza Fiumara; Vincenzo Dattilo; Enzo Gallo; Paolo Visca; Francesco Ortuso; Claudia Abbruzzese; Lorenzo Botta; Silvia Schenone; Giovanni Cuda; Stefano Alcaro; Cataldo Bianco; Patrizia Lavia; Marco G Paggi; Nicola Perrotti; Rosario Amato
Journal:  Oncotarget       Date:  2015-11-10

7.  SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.

Authors:  Cristina Talarico; Vincenzo Dattilo; Lucia D'Antona; Agnese Barone; Nicola Amodio; Stefania Belviso; Francesca Musumeci; Claudia Abbruzzese; Cataldo Bianco; Francesco Trapasso; Silvia Schenone; Stefano Alcaro; Francesco Ortuso; Tullio Florio; Marco G Paggi; Nicola Perrotti; Rosario Amato
Journal:  Oncotarget       Date:  2016-03-29

8.  Yes-activated protein promotes primary resistance of BRAF V600E mutant metastatic colorectal cancer cells to mitogen-activated protein kinase pathway inhibitors.

Authors:  Meng Su; Lei Zhan; Yong Zhang; Jingdong Zhang
Journal:  J Gastrointest Oncol       Date:  2021-06

9.  The plant-derived glucocorticoid receptor agonist Endiandrin A acts as co-stimulator of colonic epithelial sodium channels (ENaC) via SGK-1 and MAPKs.

Authors:  Dana Kuntzsch; Theresa Bergann; Petra Dames; Anja Fromm; Michael Fromm; Rohan A Davis; Matthias F Melzig; Joerg D Schulzke
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

10.  Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.

Authors:  Michael Römer; Johannes Eichner; Ute Metzger; Markus F Templin; Simon Plummer; Heidrun Ellinger-Ziegelbauer; Andreas Zell
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.